Article thumbnail

Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign

By Shelley L Deeks, Gillian H Lim, Mary Anne Simpson, Laura Rosella, Christopher O Mackie, Camille Achonu and Natasha S Crowcroft
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2010). Agency of Canada: Vaccine Surveillance Report - Adverse Events following Immunization.
  2. (2010). Crowcroft N: A seroprevalence study of pandemic influenza A H1N1 among Ontarians.
  3. Crowcroft NS: Self reported influenza A (H1N1) 2009 monovalent vaccination coverage for Ontario, Canada. Health Reports .
  4. (2010). DeStefano F: Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Deeks et al.
  5. (2009). DeStefano F: Vaccines and Guillain-Barré syndrome. Drug Saf
  6. (2009). E: Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice Research Database.
  7. (2006). Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med
  8. (2009). Guillain-Barré syndrome and influenza virus infection. Clin Inf Dis
  9. Healthcare Products Regulatory Agency: Final Public Summary: UK Suspected Adverse Reaction Analysis Swine Flu (H1N1) Vaccines - Celvapan and Pandemrix -
  10. Hofmann N: H1N1 vaccination.
  11. Interim order respecting the sale of the vaccine for the novel influenza a H1N1 virus.
  12. (1976). JA: Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States,
  13. (2008). MD: Incidence of Guillain-Barré syndrome in Alberta, Canada: an administrative data study.
  14. (2009). Nearly half of Canadians won’t get H1N1 shot: poll; Health officials try to counter fear, confusion. Reported by Meagan Fitzpatrick
  15. Ontario Ministry of Health and Long-Term Care Fact Sheet: You Call the Shot: H1N1 Public Education Campaign.
  16. (2010). Products Agency: Final summary of adverse drug reaction reports
  17. (2010). RAC: Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis
  18. (2009). results: Surveillance for Guillain-Barré syndrome after receipt of influenza A
  19. (1998). RT: The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
  20. Statistics Canada: Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual.,
  21. The Globe and Mail: Health officials scramble to counter H1N1 myths; Safety and effectiveness of vaccine emphasized in effort to reassure skeptics as conspiracy theories go viral. Reported by Caroline Alphonso
  22. The H1N1 Pandemic - How Ontario Fared: A Report by Ontario’s Chief Medical Officer of Health.
  23. (2009). Vellozzi C: Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines. Lancet